15.07.2016
AURELIUS SE & Co. KGaA DE000A0JK2A8
DGAP-News: AURELIUS Group acquires cosmetic clinic operator 'The Hospital Group'
DGAP-News: AURELIUS SE & Co. KGaA / Key word(s): Takeover
AURELIUS Group acquires cosmetic clinic operator 'The Hospital Group'
15.07.2016 / 07:00
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
AURELIUS Group acquires cosmetic clinic operator "The Hospital Group"
- Provider of surgical and non-surgical cosmetic procedures
- Complex shareholder circumstances present valuable equity acquisition
opportunity
- Large synergy potential with AURELIUS Group's established acquisition
Transform
Munich / London - July 15, 2016 - AURELIUS Group (ISIN DE000A0JK2A8) today
announces the acquisition of "The Hospital Group", a provider of surgical
and non-surgical cosmetic procedures based in Birmingham, UK. With
approximately 300 employees, The Hospital Group generated revenues of
almost EUR 40 million in 2015. The financial terms of the transaction are
undisclosed.
The Hospital Group is a leading provider of cosmetic procedures in the UK,
as well as a market leader in weight loss treatments. The Company operates
the largest cosmetic surgery hospital in Europe together with 15 clinics
across Great Britain. The Hospital Group boasts high patient satisfaction
rates in its four business areas of cosmetic surgery, weight loss, cosmetic
dentistry, and non-surgical treatments.
There is significant potential for large revenue and cost synergies between
The Hospital Group and Transform Group, which was acquired by AURELIUS in
July 2015. Transform, which comprises 27 clinics across the UK and two
dedicated cosmetic surgery hospitals in Manchester and London, is the
domestic market leader in cosmetic surgery.
"With the acquisition of The Hospital Group and Transform, we have reached
a leading position in the British market for cosmetic surgery and
treatment. We see large growth potential in this market for the coming
years," commented Gerhard Engleder, vice president of AURELIUS Group.
ABOUT AURELIUS
AURELIUS is one of the leading European investment groups. From its offices
in Munich, London, Stockholm and Madrid, AURELIUS acquires participations
with development potential. Once under the AURELIUS umbrella, the
acquisitions are given a long-term strategic orientation in order for them
to fully develop their potential.
Currently, the AURELIUS Group consists of 25 subsidiaries with locations in
Europe, Asia, and the U.S.A. These include numerous traditional consumer
brands, services businesses and a number of industrial enterprises.
Companies are acquired based on strict investment criteria without focusing
on any particular industry. Shares of AURELIUS Equity Opportunities SE &
Co. KGaA are listed in the m:access segment of the Munich Stock Exchange
and are traded on all German stock markets under ISIN DE000A0JK2A8.
To find out more, visit www.aureliusinvest.com
CONTACT
Anke Banaschewski
Investor Relations & Corporate Communications
Phone +49 (89) 544799 - 0
Fax +49 (89) 544799 - 55
[email protected]
---------------------------------------------------------------------------
15.07.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: AURELIUS SE & Co. KGaA
Ludwig-Ganghofer-Straße 6
82031 Grünwald
Germany
Phone: +49 (0)89 544 799-0
Fax: +49 (0)89 544 799-55
E-mail: [email protected]
Internet: www.aureliusinvest.de
ISIN: DE000A0JK2A8
WKN: A0JK2A
Listed: Regulated Unofficial Market in Berlin, Munich, Stuttgart;
Open Market in Frankfurt
End of News DGAP News Service
---------------------------------------------------------------------------
482657 15.07.2016
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
AURELIUS SE & Co. KGaA ISIN: DE000A0JK2A8 können Sie bei EQS abrufen
Beteiligungen , A0JK2A , AR4 , HAM:AR4